Tony Wu

Antitumor activity of margetuximab (M) plus pembrolizumab (P) in patients (pts) with advanced HER2+ (IHC3+) gastric carcinoma (GC).

J. Lacy, S. Park, Y. Bang, 2019, Journal of Clinical Oncology.

A phase 1, open label, dose escalation study of MGD009, a humanized B7-H3 x CD3 DART protein, in combination with MGA012, an anti-PD-1 antibody, in patients with relapsed or refractory B7-H3-expressing tumors.

P. Moore, J. Wigginton, J. Strauss, 2018 .

Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA

D. Berry, S. Cummings, E. Fung, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.